Patent Notices

AFREZZA® (insulin human) inhalation powder, the AFREZZA® inhaler, their components, methods of use, and methods of manufacture, are covered variously by the following U.S. patents:

 

6,444,226        Purification and stabilization of peptide and protein pharmaceutical agents

6,652,885        Purification and stabilization of peptide and protein pharmaceutical agents

7,305,986        Unit dose capsules for use in a dry powder inhaler

7,464,706        Unit dose cartridge and dry powder inhaler

7,648,960        Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles

7,709,639        Catalysis of diketopiperazine synthesis

7,799,344        Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

7,803,404        Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces

7,943,178        Methods and compositions for delivering peptides

7,943,572        Superior control of blood glucose in diabetes treatment

8,119,593        Method of treating diabetes type 2 by metformin and an ultrarapid acting insulin

8,146,588        Unit dose capsules and dry powder inhaler

8,156,936        Unit dose capsules and dry powder inhaler

8,202,992       Catalysis of diketopiperazine synthesis

8,215,300        Unit dose cartridge and dry powder inhaler

8,227,409        Diketopiperazine microparticles with defined isomer contents

8,258,095        Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content

8,389,470        Methods and compositions for delivering peptides

8,424,518        Dry powder inhaler and system for drug delivery

8,485,180        Dry powder drug delivery system

8,491,848        Reactor for producing pharmaceutical particles in a precipitation process

8,499,757        Dry powder inhaler and system for drug delivery

8,551,528        Diketopiperazine microparticles with defined specific surface areas

8,590,320       Apparatus and method for cryogranulating a pharmaceutical composition

8,623,817        Method of treating diabetes type 2 by administering ultrarapid acting insulin

8,636,001        Dry powder inhaler and system for drug delivery

8,729,019        Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

8,734,845        Diketopiperazine microparticles with defined specific surface areas

8,778,403        Diketopiperazine microparticles with defined specific surface areas

8,889,099       Methods and Compositions for Delivering Peptides

8,912,193        Dry powder inhaler and system for drug delivery

8,925,726        Blister Package For Pharmaceutical Cartridges

8,950,397       Unit Dose Cartridge And Dry Powder Inhaler

9,061,111        Unit Dose Capsules and Dry Powder Inhaler

9,089,497      Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces

9,192,675       Dry Powder Inhaler and System for Drug Delivery

9,283,193      Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

9,339,615       Dry Powder Inhaler and System for Drug Delivery

9,346,766      Catalysis of Diketopiperazine Synthesis

9,358,352     Dry Powder Drug Delivery System and Methods

9,393,372     Dry Powder Delivery System

9,446,001     Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces    

9,446,133     Dry Powder Inhaler and System for Drug Delivery

9,511,198      Dry Powder Inhaler and System for Drug Delivery

9,566,243     Apparatus and Method for Cryogranulating a Pharmaceutical Composition

D613,849      Cartridge for a dry powder inhaler

D614,760      Dry powder inhaler

D643,308      Blister packaging

D664,640      Cartridge for a dry powder inhaler

D671,842       Blister packaging

D771,237      Mouthpiece Cover

Other patents pending.

This list is provided in compliance with the virtual patent marking provisions of 35 USC §287.